14.7 C
New York
Monday, November 18, 2024

FTC Moves to Block Amgen’s $27.8 Billion Deal for Horizon Therapeutics

The Federal Trade Commission said it is seeking to block Amgen’s $27.8 billion acquisition of Horizon Therapeutics, in a rare effort by antitrust enforcers to prevent a merger of pharmaceutical companies. The FTC on Tuesday filed a lawsuit in federal court seeking an injunction that would prevent …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

156,481FansLike
396,312FollowersFollow
2,320SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x